Search results
Results from the WOW.Com Content Network
Hyderabad Pharma City, is a large pharmaceuticals industrial park being established Mucherla near Hyderabad, India by the Government of Telangana. [1] Spread over 19,000-acre (77 km 2 ), the Park is touted to be biggest of its kind industrial cluster for the pharmaceuticals for pharmaceutical companies in manufacturing and development needs.
HYDERABAD, India (Reuters) -At least 15 people were killed in an explosion on Wednesday at a pharmaceuticals manufacturing plant in southern India's Andhra Pradesh state, a district government ...
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
DD Yadagiri is a state-owned Telugu language television channel operated by India's national broadcaster Doordarshan.It is one of the 11 Indian language channels operated by Doordarshan and is telecast from Doordarshan Kendra, Hyderabad and caters the state of Telangana.
Indian Drugs and Pharmaceuticals Limited (IDPL) is a public sector pharmaceutical, bulk drug manufacturing and drug discovery company owned by the Indian government, headquartered in New Delhi, and located in Hyderabad, Gurgaon and Rishikesh.: [1] The company is involved in patent development alongside, National Institute of Pharmaceutical Education and Research to provide affordable drugs ...
Kadthal has emerged as a vibrant town along the Hyderabad Srisailam highway. Maheswara Maha Pyramid, Kadthal Main Rd [2] [3] and Maisigandi Maisamma Temple, Kadthal are popular attractions located close to Kadthal town. The upcoming Hyderabad Pharma City is in close proximity to the Kadthal town. [4] The villages in Kadthal mandal include: 1.
Related: Step by Step Cast Reunites at 90s Con and Remembers Suzanne Somers 5 Months After Her Death Elsewhere in the interview, Duffy told the story of meeting his wife of 46 years, the late ...
In 2018, [22] and 2019, [23] Aurobindo Pharma USA recalled tablets containing valsartan due to the detection of N-Nitrosodiethylamine (NDEA) which is a probable human carcinogen. In November 2019, Aurobindo Pharma USA recalled ranitidine tablets, capsules, and syrup due to the detection of unacceptable levels of N-nitrosodimethylamine (NDMA). [24]